Raytheon Technologies Work in process increased by 8.6% to $4.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $4.87B to $4.95B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 9.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.31B | $3.30B | $3.09B | $3.47B | $3.63B | $3.75B | $3.84B | $3.99B | $4.19B | $4.30B | $4.16B | $4.38B | $4.69B | $4.77B | $4.49B | $4.87B | $4.82B | $4.77B | $4.55B | $4.95B |
| QoQ Change | — | -0.4% | -6.4% | +12.5% | +4.5% | +3.3% | +2.5% | +4.0% | +4.8% | +2.7% | -3.1% | +5.3% | +6.9% | +1.9% | -5.9% | +8.4% | -1.0% | -1.0% | -4.6% | +8.6% |
| YoY Change | — | — | — | — | +9.7% | +13.7% | +24.4% | +15.1% | +15.4% | +14.7% | +8.4% | +9.8% | +11.9% | +11.1% | +8.0% | +11.1% | +2.9% | +0.0% | +1.4% | +1.5% |
| % of Inventories | 34.6% | 35.0% | 33.6% | 35.6% | 35.8% | 35.9% | 36.2% | 35.3% | 34.9% | 35.7% | 35.3% | 35.4% | 35.9% | 35.4% | 35.2% | 35.8% | 34.4% | 34.6% | 34.1% | 34.9% |
| Share Change | — | +0.3pp | -1.3pp | +2.0pp | +0.2pp | +0.1pp | +0.3pp | -0.9pp | -0.4pp | +0.8pp | -0.3pp | +0.1pp | +0.5pp | -0.5pp | -0.3pp | +0.6pp | -1.3pp | +0.2pp | -0.5pp | +0.9pp |